EP0753006A4 - Vpr AND Vpx PROTEINS OF HIV - Google Patents
Vpr AND Vpx PROTEINS OF HIVInfo
- Publication number
- EP0753006A4 EP0753006A4 EP95912976A EP95912976A EP0753006A4 EP 0753006 A4 EP0753006 A4 EP 0753006A4 EP 95912976 A EP95912976 A EP 95912976A EP 95912976 A EP95912976 A EP 95912976A EP 0753006 A4 EP0753006 A4 EP 0753006A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- vpr
- hiv
- vpx proteins
- vpx
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM4697A AUPM469794A0 (en) | 1994-03-25 | 1994-03-25 | Therapeutic compounds |
AUPM4697/94 | 1994-03-25 | ||
AUPN0902/95 | 1995-02-03 | ||
AUPN0902A AUPN090295A0 (en) | 1995-02-03 | 1995-02-03 | Therapeutic compounds |
PCT/AU1995/000169 WO1995026361A1 (en) | 1994-03-25 | 1995-03-24 | Vpr AND Vpx PROTEINS OF HIV |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0753006A1 EP0753006A1 (en) | 1997-01-15 |
EP0753006A4 true EP0753006A4 (en) | 1999-04-14 |
Family
ID=25644649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95912976A Withdrawn EP0753006A4 (en) | 1994-03-25 | 1995-03-24 | Vpr AND Vpx PROTEINS OF HIV |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0753006A4 (en) |
JP (1) | JPH09511395A (en) |
CA (1) | CA2186398A1 (en) |
WO (1) | WO1995026361A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780220A (en) * | 1994-05-19 | 1998-07-14 | Trustees Of The University Of Pennsylvania | Methods and compositions for inhibiting HIV replication |
WO1996032494A1 (en) * | 1995-04-14 | 1996-10-17 | University Of Alabama Research Foundation | Fusion protein delivery system and uses thereof |
US6087486A (en) * | 1996-01-29 | 2000-07-11 | The Trustees Of The University Of Pennsylvania | Nucleotide sequences encoding vpr receptor protein |
AUPO258196A0 (en) * | 1996-09-27 | 1996-10-17 | Australian National University, The | Method for determining ion channel activity of a substance |
WO1998035234A1 (en) * | 1997-02-11 | 1998-08-13 | The Regents Of The University Of California | Identifying agents for treating lentiviral infection |
US7622300B2 (en) | 1998-06-03 | 2009-11-24 | Kappes John C | Trans-lentiviral vector particles and transduction of eukaryotic cells therewith |
US6555342B1 (en) | 1998-06-03 | 2003-04-29 | Uab Research Foundation | Fusion protein delivery system and uses thereof |
US6984486B1 (en) | 1999-02-19 | 2006-01-10 | J. David Gladstone Institutes | Synthetic peptide of regulatory virus protein R (VPR) of human immunodeficiency virus type 1 (HIV-1) and the utilization thereof |
DE19908752A1 (en) * | 1999-02-19 | 2000-08-31 | Ulrich Schubert | New synthetic peptides from the Vpr protein of human immune deficiency virus, useful e.g. for therapy and diagnosis, have good solubility in water |
WO2000049038A2 (en) | 1999-02-19 | 2000-08-24 | Ulrich Schubert | Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
DE19908766C2 (en) * | 1999-02-19 | 2001-02-15 | Ulrich Schubert | Use of synthetic Vpr peptides of the human immunodeficiency virus type 1 (HIV-1) for the development of therapeutic and diagnostic reagents |
US6664040B2 (en) * | 2000-05-23 | 2003-12-16 | The Regents Of The University Of California | Compositions and methods for delivery of a molecule into a cell |
AU2002350047A1 (en) * | 2001-10-29 | 2003-05-12 | Genzyme Corporation | Therapeutic anti-hiv (vpr) compounds |
WO2005032561A1 (en) * | 2003-10-03 | 2005-04-14 | Riken | INVENTION RELATING TO FUNCTION OF HIV-Vpr |
FR2868841B1 (en) * | 2004-04-09 | 2006-07-14 | Bioalliance Pharma Sa | METHOD OF IDENTIFYING ACTIVE COMPOUNDS ON THE REPLICATION OF THE HIV VIRUS |
WO2005103654A2 (en) * | 2004-04-09 | 2005-11-03 | Bioalliance Pharma | Method for identification of compounds active in hiv virus replication |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015875A1 (en) * | 1989-06-02 | 1990-12-27 | Dana Farber Cancer Institute | Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
WO1994019456A1 (en) * | 1993-02-19 | 1994-09-01 | Weiner David B | Vpr function and activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE147782T1 (en) * | 1990-07-12 | 1997-02-15 | Harvard College | PRIMATE LENTIVIRUS VACCINES |
US6107062A (en) * | 1992-07-30 | 2000-08-22 | Inpax, Inc. | Antisense viruses and antisense-ribozyme viruses |
AU5848794A (en) * | 1993-02-05 | 1994-08-29 | Regents Of The University Of California, The | Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use |
-
1995
- 1995-03-24 JP JP7524870A patent/JPH09511395A/en active Pending
- 1995-03-24 EP EP95912976A patent/EP0753006A4/en not_active Withdrawn
- 1995-03-24 CA CA002186398A patent/CA2186398A1/en not_active Abandoned
- 1995-03-24 WO PCT/AU1995/000169 patent/WO1995026361A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015875A1 (en) * | 1989-06-02 | 1990-12-27 | Dana Farber Cancer Institute | Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
WO1994019456A1 (en) * | 1993-02-19 | 1994-09-01 | Weiner David B | Vpr function and activity |
Non-Patent Citations (3)
Title |
---|
COHEN E A ET AL.: "Identification of HIV-1 vpr product and function", JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, vol. 3, no. 1, 1990, new york, pages 11 - 18, XP002085625 * |
See also references of WO9526361A1 * |
ZHANG S ET AL: "Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, vol. 212, no. 2, 8 June 1998 (1998-06-08), pages 157-166, XP004122917 * |
Also Published As
Publication number | Publication date |
---|---|
WO1995026361A1 (en) | 1995-10-05 |
JPH09511395A (en) | 1997-11-18 |
CA2186398A1 (en) | 1995-10-05 |
EP0753006A1 (en) | 1997-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL109160A0 (en) | Conjugates of proteins and bifunctional ligands | |
AU673703B2 (en) | Injector and use of the same | |
AU5743694A (en) | Anastomosis stent and stent selection system | |
AU5422696A (en) | Nox catalyst and method of using the same | |
ZA945720B (en) | Electrode and preparation thereof | |
EP0753006A4 (en) | Vpr AND Vpx PROTEINS OF HIV | |
AU5656594A (en) | Dialysis probes | |
HUP9603071A2 (en) | Purin-6-one derivatives and pharmaceuticals preparations containing them | |
GB2276245B (en) | Transducer assembly and method | |
HUP9900357A3 (en) | Pharmaceutical combination preparations containing erythropoietin and iron preparations | |
ZA96610B (en) | Preparation of n-aryl and n-hetaryhydroxylamines | |
ZA941111B (en) | Vpr function and activity | |
AU8427091A (en) | Gamma-carboxylase and methods of use | |
AU6097090A (en) | Rapid hair ph indication and solution therefor | |
AU4682593A (en) | Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity | |
GB9203041D0 (en) | Joints and connectors | |
GB9423372D0 (en) | Proteins and their uses | |
HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof | |
AU6975996A (en) | Stabilized agchemical concentrate and use thereof | |
AU5043890A (en) | Integrate and hold amplifier | |
HUP9602220A2 (en) | Substituted 4h-piranes and pharmaceutical preparations containing them | |
IL118629A0 (en) | N-Substituted cis-N-propenyl-acetemides their preparation and use | |
AU6410490A (en) | Transformer and connector assembly | |
PL324340A1 (en) | Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids | |
AU5841696A (en) | Preparation and use of contrast agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960916 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB IT |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19990302 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): DE FR GB IT |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20021031 |